These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 22954747)

  • 1. Trypanosoma cruzi carrying a monoallelic deletion of the calreticulin (TcCRT) gene are susceptible to complement mediated killing and defective in their metacyclogenesis.
    Sánchez Valdéz FJ; Pérez Brandán C; Zago MP; Labriola C; Ferreira A; Basombrío MÁ
    Mol Immunol; 2013 Mar; 53(3):198-205. PubMed ID: 22954747
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A monoallelic deletion of the TcCRT gene increases the attenuation of a cultured Trypanosoma cruzi strain, protecting against an in vivo virulent challenge.
    Sánchez-Valdéz FJ; Pérez Brandán C; Ramírez G; Uncos AD; Zago MP; Cimino RO; Cardozo RM; Marco JD; Ferreira A; Basombrío MÁ
    PLoS Negl Trop Dis; 2014 Feb; 8(2):e2696. PubMed ID: 24551259
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular mechanisms involved in the inactivation of the first component of human complement by Trypanosoma cruzi calreticulin.
    Valck C; Ramírez G; López N; Ribeiro CH; Maldonado I; Sánchez G; Ferreira VP; Schwaeble W; Ferreira A
    Mol Immunol; 2010 Apr; 47(7-8):1516-21. PubMed ID: 20153898
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Trypanosoma cruzi calreticulin: a novel virulence factor that binds complement C1 on the parasite surface and promotes infectivity.
    Ramírez G; Valck C; Molina MC; Ribeiro CH; López N; Sánchez G; Ferreira VP; Billetta R; Aguilar L; Maldonado I; Cattán P; Schwaeble W; Ferreira A
    Immunobiology; 2011; 216(1-2):265-73. PubMed ID: 20472323
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeted deletion of the gp72 gene decreases the infectivity of Trypanosoma cruzi for mice and insect vectors.
    Basombrío MA; Gómez L; Padilla AM; Ciaccio M; Nozaki T; Cross GA
    J Parasitol; 2002 Jun; 88(3):489-93. PubMed ID: 12099416
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Trypanosoma cruzi Calreticulin Topographical Variations in Parasites Infecting Murine Macrophages.
    González A; Valck C; Sánchez G; Härtel S; Mansilla J; Ramírez G; Fernández MS; Arias JL; Galanti N; Ferreira A
    Am J Trop Med Hyg; 2015 May; 92(5):887-97. PubMed ID: 25758653
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Trypanosoma cruzi calreticulin: a possible role in Chagas' disease autoimmunity.
    Ribeiro CH; López NC; Ramírez GA; Valck CE; Molina MC; Aguilar L; Rodríguez M; Maldonado I; Martínez R; González C; Troncoso R; Lavandero S; Gingras AR; Schwaeble W; Ferreira A
    Mol Immunol; 2009 Mar; 46(6):1092-9. PubMed ID: 19108895
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Exogenous Calreticulin, incorporated onto non-infective Trypanosoma cruzi epimastigotes, promotes their internalization into mammal host cells.
    Sosoniuk-Roche E; Vallejos G; Aguilar-Guzmán L; Pizarro-Bäuerle J; Weinberger K; Rosas C; Valck C; Michalak M; Ferreira A
    Immunobiology; 2017 Mar; 222(3):529-535. PubMed ID: 27839837
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Variable numbers of calreticulin genes in Trypanosoma cruzi correlate with atypical morphology and protein expression.
    González A; Härtel S; Mansilla J; Sánchez-Valdéz F; Ferreira A
    Immunobiology; 2018 Dec; 223(12):802-806. PubMed ID: 30131175
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Trypanosoma cruzi calreticulin inhibits the complement lectin pathway activation by direct interaction with L-Ficolin.
    Sosoniuk E; Vallejos G; Kenawy H; Gaboriaud C; Thielens N; Fujita T; Schwaeble W; Ferreira A; Valck C
    Mol Immunol; 2014 Jul; 60(1):80-5. PubMed ID: 24769495
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of early lectin pathway activation in the complement-mediated killing of Trypanosoma cruzi.
    Cestari Idos S; Krarup A; Sim RB; Inal JM; Ramirez MI
    Mol Immunol; 2009 Dec; 47(2-3):426-37. PubMed ID: 19783051
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The classical activation pathway of the human complement system is specifically inhibited by calreticulin from Trypanosoma cruzi.
    Ferreira V; Valck C; Sánchez G; Gingras A; Tzima S; Molina MC; Sim R; Schwaeble W; Ferreira A
    J Immunol; 2004 Mar; 172(5):3042-50. PubMed ID: 14978109
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An in vivo role for Trypanosoma cruzi calreticulin in antiangiogenesis.
    Molina MC; Ferreira V; Valck C; Aguilar L; Orellana J; Rojas A; Ramirez G; Billetta R; Schwaeble W; Lemus D; Ferreira A
    Mol Biochem Parasitol; 2005 Apr; 140(2):133-40. PubMed ID: 15760653
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intracellular growth and metacyclogenesis defects in Trypanosoma cruzi carrying a targeted deletion of a Tc52 protein-encoding allele.
    Allaoui A; François C; Zemzoumi K; Guilvard E; Ouaissi A
    Mol Microbiol; 1999 Jun; 32(6):1273-86. PubMed ID: 10383767
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The interaction of classical complement component C1 with parasite and host calreticulin mediates Trypanosoma cruzi infection of human placenta.
    Castillo C; Ramírez G; Valck C; Aguilar L; Maldonado I; Rosas C; Galanti N; Kemmerling U; Ferreira A
    PLoS Negl Trop Dis; 2013; 7(8):e2376. PubMed ID: 23991234
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    Ramírez-Toloza G; Ferreira A
    Front Microbiol; 2017; 8():1667. PubMed ID: 28919885
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Extracellular Trypanosoma cruzi calreticulin in the host-parasite interplay.
    Ramírez G; Valck C; Ferreira VP; López N; Ferreira A
    Trends Parasitol; 2011 Mar; 27(3):115-22. PubMed ID: 21288773
    [TBL] [Abstract][Full Text] [Related]  

  • 18. F(ab')2 antibody fragments against Trypanosoma cruzi calreticulin inhibit its interaction with the first component of human complement.
    Aguilar L; Ramírez G; Valck C; Molina MC; Rojas A; Schwaeble W; Ferreira V; Ferreira A
    Biol Res; 2005; 38(2-3):187-95. PubMed ID: 16238097
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Complement C2 receptor inhibitor trispanning confers an increased ability to resist complement-mediated lysis in Trypanosoma cruzi.
    Cestari Idos S; Evans-Osses I; Freitas JC; Inal JM; Ramirez MI
    J Infect Dis; 2008 Nov; 198(9):1276-83. PubMed ID: 18781865
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biological characterization of Trypanosoma cruzi stocks from Chilean insect vectors.
    Solari A; Wallace A; Ortiz S; Venegas J; Sanchez G
    Exp Parasitol; 1998 Jul; 89(3):312-22. PubMed ID: 9676709
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.